Jefferies upgraded Chemed from Hold to Buy and set a new price target of $550.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/2/2025 | $550.00 | Hold → Buy | Jefferies |
| 7/25/2025 | $500.00 | Hold | Jefferies |
| 3/4/2022 | $609.00 → $579.00 | Outperform | RBC Capital |
| 7/29/2021 | $604.00 → $609.00 | Outperform | RBC Capital |
CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the
Stacy Noland reveals how VITAS brought comfort and dignity during her mother's final days. MIRAMAR, Fla., Nov. 25, 2025 /PRNewswire/ -- A new video released by VITAS Healthcare during National Care at Home Month spotlights the hospice story of Stacy Noland and her mother, Sonia Lindo, whose final chapter was marked by compassion and dignity. The expert end-of-life care they received allowed Noland to focus on what mattered most: being a daughter. Lindo, a Jamaican-born cardiac nurse of 30 years saved countless lives before facing her own terminal diagnosis. "When my mother got sick, it stunned me," Noland said. "She was strong, healthy and dedicated to her patie
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hos
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
10-Q - CHEMED CORP (0000019584) (Filer)
8-K - CHEMED CORP (0000019584) (Filer)
10-Q - CHEMED CORP (0000019584) (Filer)
Jefferies upgraded Chemed from Hold to Buy and set a new price target of $550.00
Jefferies initiated coverage of Chemed with a rating of Hold and set a new price target of $500.00
RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hos
CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2025, versus the comparable prior-year period. Results for Quarter Ended September 30, 2025 Consolidated operating results: Revenue increased 3.1% to $624.9 millionGAAP Diluted Earnings-per-Share (EPS) of $4.46, a decrease of 10.8%Adjusted Diluted EPS of $5.27, a decrease of 6.6% VITAS segment operating results: Net Pati
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 29, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/9m3ch5my. Participants may also register via teleconference a
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE:CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare. A Media Snippet accompanying this announcement is available by clicking on this link. Westfall has served as CEO since 2016, leading VITAS through a period of meaningful growth, operational transform
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra
Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t
SC 13G/A - CHEMED CORP (0000019584) (Subject)
SC 13G/A - CHEMED CORP (0000019584) (Subject)
SC 13G/A - CHEMED CORP (0000019584) (Subject)